A recent study, comparing obese T2D patients with non-T2D obese patients and healthy controls, investigated the in vivo activities and protein expressions of CYP2C9, CYP1A2, CYP3A, CYP2C19 [116]. This evidence concerns the gene CYP1A2 and type 2 diabetes mellitus.